Alumis reports Phase 3 psoriasis trial results for envudeucitinib

Mar 28, 2026 - 19:00

0

Alumis reports Phase 3 psoriasis trial results for envudeucitinib

Related Posts

ZipRecruiter president David Travers sells $106,161 in stock

ZipRecruiter president David Travers sells $106,161 in ...

Mar 21, 2025 1

ZipRecruiter SVP Bartolome Lora sells $12,861 in shares

ZipRecruiter SVP Bartolome Lora sells $12,861 in shares

Mar 21, 2025 1

Businesses may have to pass high beef prices on to consumers

Businesses may have to pass high beef prices on to cons...

Mar 21, 2025 4

Dream Finders Homes director Lovett sells $2.65 million in stock

Dream Finders Homes director Lovett sells $2.65 million...

Mar 21, 2025 0

Elon Musk reassures Tesla workers with all-hands meeting, admits it 'feels like Armageddon'

Elon Musk reassures Tesla workers with all-hands meetin...

Mar 21, 2025 7

Atea Pharmaceuticals Issues Statement Regarding Director Nominations

Atea Pharmaceuticals Issues Statement Regarding Directo...

Mar 21, 2025 3